Verrica Pharmaceuticals (VRCA) Interest Coverage Ratio (2017 - 2026)
Verrica Pharmaceuticals (VRCA) posted quarterly Interest Coverage Ratio of 9.42 for Q1 2026, down 155.33% year-over-year from 17.03 in Q1 2025, and down 344.02% quarter-over-quarter from 2.12 in Q4 2025.
Verrica Pharmaceuticals (VRCA) Interest Coverage Ratio (2017 - 2026) Analysis & Trends
Verrica Pharmaceuticals' Interest Coverage Ratio history runs 10 years deep, the most recent figure standing at 9.42 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 155.33% year-over-year to 9.42; the TTM figure through Mar 2026 stood at 13.36 (down 95.99% YoY), while the FY2025 annual figure was 0.17, up 82.23% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 9.42, down from 2.12 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 14.48 in Q3 2022, with the low at 16.17 in Q4 2022.
- The 5-year median for Interest Coverage Ratio is 5.06 (2024), against an average of 4.58.
- The sharpest annual moves came in 2022 and 2025: Interest Coverage Ratio jumped 235.35% in 2022, then plunged 53253.85% in 2025.
- Verrica Pharmaceuticals' Interest Coverage Ratio stood at 16.17 in 2022, then climbed by 21.96% to 12.62 in 2023, then jumped by 47.84% to 6.58 in 2024, then soared by 67.77% to 2.12 in 2025, then sank by 344.02% to 9.42 in 2026.
- Business Quant data shows VRCA's Interest Coverage Ratio at 9.42 in Q1 2026, 2.12 in Q4 2025, and 0.28 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | Verrica Pharmaceuticals | 102.80 Mn | 91.60 Mn | - | -79.86 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.61 |
| Mar 31, 2026 | -9.42 |
| Dec 31, 2025 | -2.12 |
| Sep 30, 2025 | 0.28 |
| Jun 30, 2025 | 0.52 |
| Mar 31, 2025 | -3.69 |
| Dec 31, 2024 | -6.58 |
| Sep 30, 2024 | -1.98 |
| Jun 30, 2024 | -6.42 |
| Mar 31, 2024 | -0.01 |
| Dec 31, 2023 | -12.62 |
| Sep 30, 2023 | -14.43 |
| Mar 31, 2023 | -1.65 |
| Dec 31, 2022 | -16.17 |
| Sep 30, 2022 | 14.48 |
| Jun 30, 2022 | -6.63 |
| Mar 31, 2022 | -6.85 |
| Dec 31, 2021 | -3.88 |
| Sep 30, 2021 | -10.70 |
| Jun 30, 2021 | -1.46 |